Work

MA09.11 Mechanisms of Resistance to MET Tyrosine Kinase Inhibitors in Patients with MET Exon 14 Mutant Non-Small Cell Lung Cancer

Year: 2019

Type: conference-abstract

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2019.08.573

Authors: G. Recondo, M. Bahcall, L. Sholl, G. Leonardi, B. Ricciuti, T. Nguyen, D. Venkatraman, G. Lamberti, R. Umeton, P. Jänne, M. Awad

Institutions: Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, Brigham and Women's Hospital, Harvard University

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2981592530

Cites:

Cited by: 4

Related to: 10